Bristol John W & CO Inc Amgen Inc Transaction History

Bristol John W & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $270,874 - $309,991	-1,362 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $19,528 - $22,756	-88 Reduced 6.07%	1,362 $339,000
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $258,680 - $301,962	1,450 New	1,450 $282,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bristol John W & CO Inc , based on Form 13F filings with the SEC.

Stay updated on Bristol John W & CO Inc with notifications on news.